Ranbaxy net profit rises

BS 200 Scorecard

 PAT grew 29 per cent at Rs 205.1 crore (Rs 159.4 crore). The board approved the payment of an interim dividend of Rs 5 per share (record date: October 30, 2003). Consolidated profit after tax grew 33 per cent at $41 million ($31 million).

 D S Brar, CEO & managing director, Ranbaxy, said: